tiprankstipranks
Protagenic Therapeutics, Inc. (PTIX)
:PTIX
US Market

Protagenic Therapeutics (PTIX) Income Statement

Compare
37 Followers

Protagenic Therapeutics Income Statement

Last quarter (Q3 2024), Protagenic Therapeutics's total revenue was $25.14K, an increase of Infinity% from the same quarter last year. In Q3, Protagenic Therapeutics's net income was $-640.78K. See Protagenic Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -28.22K$ -30.00$ 0.00$ -286.00$ -339.00
Operating Expenses
$ 4.53M$ 3.56M$ 4.14M$ 2.55M$ 2.09M
Depreciation and Amortization
$ 28.22K$ 30.00$ 286.00$ 286.00$ 339.00
EBITDA
$ -4.50M$ -3.42M$ -4.14M$ -2.55M$ -2.09M
Operating Income
$ -4.53M$ -3.56M$ -4.14M$ -2.55M$ -2.09M
Other Income/Expenses
$ -473.52K$ 2.28K$ -382.52K$ 2.88K$ 335.22K
Pretax Income
$ -5.00M$ -3.56M$ -4.52M$ -2.55M$ -1.75M
Net Income
$ -5.00M$ -3.60M$ -4.99M$ -2.79M$ -1.77M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.15$ -0.83$ -1.35$ -1.08$ -0.69
Diluted EPS
$ -1.15$ -0.83$ -1.35$ -1.08$ -0.69
Weighted Average Shares Outstanding
4.34M 4.32M 3.69M 2.58M 2.57M
Weighted Average Shares Outstanding (Diluted)
4.34M 4.32M 3.69M 2.58M 2.57M
Currency in USD

Protagenic Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis